Tabelecleucel for treating post-transplant lymphoproliferative disorder caused by the Epstein-Barr virus (terminated appraisal)

Technology appraisal
Reference number: TA923
Published: 19 October 2023

History

Topic selection

Supporting documentation (MSWord 55 KB)

Published:

10 November 2022

Invitation to participate

Final scope (PDF 196 KB)

Published:

31 October 2022
Final stakeholder list (PDF 199 KB)

Published:

31 October 2022
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 407 KB)

Published:

31 October 2022
Equality impact assessment (Scoping) (PDF 138 KB)

Published:

31 October 2022

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 183 KB)

Published:

09 June 2022
Draft matrix post referral (PDF 204 KB)

Published:

09 June 2022